Business
PureTech to Present at Barclays Healthcare Conf
PureTech to Present at Barclays Healthcare Conf.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n 1 March 2023\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech to Present at the Barclays Global Healthcare Conference\n \n \n \n \n \n PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Bharatt Chowrira, Ph.D., J.D., President and Chief Business, Finance and Operating Officer, and Eric Elenko, Ph.D., Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT. A webcast of the presentation will be available athttps://investors.puretechhealth.com.\n \n \n \n \n About PureTech Health\n \n PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 26 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that will soon be filed for FDA approval, as of the most recent update by the Company. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.\n \n For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.\n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation those related to our upcoming presentation at the Barclays Global Healthcare Confere...